Biologik ApS: Financial statements 2020
CVR: 36070498
Source: annual report 2020, Danish Business Authority
01/07/2019 – 30/06/2020
Biologik ApS (CVR 36070498) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 377,588 and a net result of DKK 61,680 compared with DKK 183,339 the year before. That is a decrease of 54.6% compared with the year before. Equity in the 2020 report amounted to DKK 198,835. The solvency ratio was 49.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 377,588
- Profit/Loss
- DKK 61,680
- Equity
- DKK 198,835
- Total Assets
- DKK 399,120
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 378 t. | 62 t. | 199 t. | 1 |
| 2019 | - | 832 t. | 183 t. | 237 t. | 1 |
| 2018 | - | 714 t. | 174 t. | 107 t. | 1 |
| 2017 | - | 142 t. | 47 t. | -67 t. | 1 |
| 2016 | - | 127 t. | -94 t. | -114 t. | - |
Official annual report
How creditworthy is Biologik ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout Biologik ApS
Biologik ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2014. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The management consists of Anette Sams Nielsen. The company is owned by Helms & Sams ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 385,601 and a net result of DKK 234,499 compared with DKK -35,348 the year before. Equity in the 2025 report amounted to DKK 408,578.